Latest filing published 02 Oct 2026 for Recursion Pharmaceuticals, INC.. Read the official filing
No signal scores available.
Zavain Dar discloses dealings in Recursion Pharmaceuticals, Inc. to SEC (Form 4). The record holds 23 filings, for trades running from 7 December 2021 to 1 October 2026.
The open-market record consists of 1 sale worth €167k, with no purchase. Outside the open market, there are 20 share grants.
On 2 October 2026 came the latest disclosure, a share grant in Recursion Pharmaceuticals, Inc. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. Section 16 rules allow two business days to file each Form 4. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
23 of 23 declarations